ストックスクリーナーアプリを入手
7.48
1.63%
0.12
CorMedix Inc (CRMD) 最新ニュース
CorMedix Buyback And Melinta Integration Reframe Anti Infectives Growth Story - Yahoo Finance
Aug Wrap: What makes CorMedix Inc stock attractive todayMarket Sentiment Summary & Capital Protection Trade Alerts - baoquankhu1.vn
CorMedix to Participate in Upcoming Investor Conferences - GlobeNewswire
CorMedix Inc. (CRMD) board approves multi-year $75M stock buyback - MSN
CorMedix Inc. (CRMD) Board Approves Multi-Year $75M Stock Buyback - Insider Monkey
Citizens reiterates Market Outperform rating on CorMedix stock By Investing.com - Investing.com Canada
Why is CorMedix Inc stock going downWeekly Gains Report & Free Community Supported Trade Ideas - baoquankhu1.vn
CorMedix Banks on DefenCath Sales in Q4 as Melinta Adds Upside - Yahoo Finance
Analyst Expectations For Cormedix's Future - Benzinga
10 Best Long Term Healthcare Stocks to Buy - Insider Monkey
Why CorMedix could be the biopharma name to watch early in 2026 - MSN
Cormedix Inc (CRMD) Live Share Price, Invest From India - INDmoney
EV Market: What makes CorMedix Inc stock attractive todayTrade Exit Summary & Weekly High Conviction Trade Ideas - baoquankhu1.vn
CorMedix Inc. (NASDAQ:CRMD) Not Doing Enough For Some Investors As Its Shares Slump 35% - simplywall.st
CorMedix Inc. (CRMD) Stock Analysis: A Biotech Company with Over 100% Potential Upside - DirectorsTalk Interviews
CorMedix sets $75M stock buyback plan - MSN
CorMedix stock rises after announcing $75 million share buyback plan By Investing.com - Investing.com South Africa
CorMedix stock rises after announcing $75 million share buyback plan - Investing.com
CorMedix announces $75 million share repurchase program By Investing.com - Investing.com Canada
CorMedix Announces $75 Mln Share Buyback Program - Nasdaq
CorMedix Therapeutics Announces Share Repurchase Program - The Manila Times
Setup Watch: Is CorMedix Inc benefiting from interest rate changesAnalyst Downgrade & Reliable Trade Execution Plans - baoquankhu1.vn
Assessing CorMedix (CRMD) Valuation After Recent Share Price Pressure And Long Term Gains - Yahoo Finance
CorMedix Analyst Day To Clarify REZZAYO And DefenCath Phase III Path - Yahoo Finance
H.C. Wainwright Signal Clinical Data to Drive CorMedix Inc. (CRMD) Future Over Commercial Performance - Finviz
CorMedix Inc. (CRMD) Stock Analysis: Exploring an 85% Potential Upside with Strong Buy Ratings - DirectorsTalk Interviews
CRMD Down 31% in a Month: Is This an Indication to Sell the Stock? - Finviz
Risk Check: Can SPNT expand its profit margins2025 Investor Takeaways & Weekly Watchlist for Consistent Profits - baoquankhu1.vn
What is the long term forecast for CorMedix Inc. stockTrade Performance Summary & Daily Momentum Trading Reports - Mfd.ru
Market Leaders: Will CorMedix Inc benefit from seasonality2025 Performance Recap & Expert Curated Trade Setup Alerts - baoquankhu1.vn
CorMedix Therapeutics to Host In-Person and Virtual Analyst Day in New York on February 10, 2026 - marketscreener.com
Will CRMD's bearish 2026 view impact DefenCath's long-term adoption? - MSN
Published on: 2026-01-26 05:38:56 - baoquankhu1.vn
Is CorMedix (CRMD) A Potential Opportunity After Recent Share Price Volatility? - simplywall.st
H.C. Wainwright Maintains CorMedix(CRMD.US) With Buy Rating, Cuts Target Price to $13 - 富途牛牛
Will CRMD'S Bearish 2026 View Impact DefenCath's Long-Term Adoption? - Yahoo Finance
CorMedix director Dillione sells $68,800 in shares By Investing.com - Investing.com Nigeria
CorMedix director Dillione sells $68,800 in shares - Investing.com
Guidance Update: What is the next catalyst for Pyxis Tankers Inc Equity WarrantWeekly Trade Report & High Return Trade Opportunity Guides - baoquankhu1.vn
Where Cormedix Stands With Analysts - Benzinga
RBC Capital Lowers Price Target for CRMD, Maintains Outperform R - GuruFocus
CorMedix (CRMD) price target decreased by 11.28% to 17.19 - MSN
CorMedix Investors Seek First OK Of Governance Reform Deal - Law360
0.13%
0.84%
大文字化:
|
ボリューム (24 時間):